Indian startups secured $68.4 million in fresh capital during the first week of January 2026, a 34% decline from the previous week. Health Tech led investments, with Even Healthcare raising $20 million, as funding trends showed a slowdown, particularly for B2C ventures. Several other startups across E-commerce and AI sectors also attracted capital.
Funding Dip Continues
Indian startups collectively raised $68.4 million across 19 funding rounds between January 5 and 9, 2026. This figure represents a significant 34% decrease compared to the $104.2 million secured in the preceding week, indicating a continued slowdown in venture capital activity.
Health Tech Leads Sector Investments
The Health Tech sector topped the funding charts, attracting $20.4 million. Even Healthcare secured the largest individual cheque of the week, raising $20 million for its telemedicine platform. Other notable investments in this space also contributed to the sector's lead.
E-commerce and AI Activity
The E-commerce sector demonstrated resilience, with five Direct-to-Consumer (D2C) startups raising a combined $9.7 million. The Artificial Intelligence (AI) sector also saw traction, with several application layer startups securing seed funding rounds.
B2C Dominance and Seed Stage Focus
Business-to-Consumer (B2C) oriented startups garnered the majority of the capital deployed, accounting for 70% of the total weekly funds. Seed-stage startups performed well, collectively securing $16.8 million across six funding deals, signaling continued investor interest in early-stage ventures.
Other Market Developments
In other significant news, media SaaS giant Amagi filed its Red Herring Prospectus for an IPO, marking a potential early-year debut. Merger talks between edtech firms upGrad and Unacademy reportedly failed due to valuation disagreements. Fintech unicorn Razorpay is said to be preparing for its IPO, potentially involving a INR 4,500 crore fresh issue. The Tamil Nadu government launched a dedicated startup policy with INR 100 crore to foster deeptech innovation.
Disclaimer:This content is for educational and informational purposes only
and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell
any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as
markets involve risk and past performance does not guarantee future results. The publisher and authors
accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy
and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.
